Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

American Journal of Gastroenterology

Volumn 100, Issue 7, 2005, Pages 1516-1522

  Floreani, Annarosa ^a,b   Rizzotto, Erik Rosa ^a   Ferrara, Francesco ^a   Carderi, Isabella ^a   Caroli, Diego ^a   Blasone, Luigi ^a   Baldo, Vincenzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Surgical and Gastroenterological Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; STEROID; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER TUMOR; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; ADULT; CHOLAGOGUES AND CHOLERETICS; CHOLANGITIS, SCLEROSING; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSION; MALE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYNDROME; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 22744441219     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41841.x     Document Type: Article

References (27)

1. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 2001;33:994-1002.
2. Durazzo M, Premoli A, Fagooneee S, et al. Overlap syndromes of autoimmune hepatitis. What is known so far. Dig Dis Sci 2003;48:423-30.
3. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16 year prospective study. Hepatology 2001;33:544-53.
4. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
5. Czaja AJ, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-14.
6. Boberg KM, Fausa O, Haaland T, et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 1996;23:1369-76.
7. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: An evaluation of a modified scoring system. J Hepatol 2000;33:537-42.
8. Van Buuren HR, van Hoogstraten HJF, Terkivatan T, et al. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000;33:543-8.
9. Muratori L, Cassani P, Pappas G, et al. The hepatic/cholestatic "overlap" sindrome. An Italian experience. Autoimmunity 2002;35:565-8.
10. Truelowe SC, Witts LJ. Cortisone in ulcerative colitis. Final report in a therapeutic trial. BMJ 1955;5:1041-8.
11. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
12. Kim WR, Therneau TM, Wiesner RH, et al. A revised natural history model for primary sclerosing cholangitis obviates the need for liver histology. Mayo Clin Proc 2000;75:688-94.
13. Ludwid J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989;13(suppl 1):43-9.
14. Minuk GY, Sutherland LR, Pappas SC, et al. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988;2:22-7.
15. Rabinovitz M, Demetris AJ, Bou-Abboud CF, et al. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992;37:1606-11.
16. Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 1992;14:325-31.
17. Lawrence SP, Sherman KE, Lawson JM, et al. A 39 year old man with chronic hepatitis. Semin Liver Dis 1994;14:97-105.
18. Wurbs D, Klein R, Terraccciano LM, et al. A 28-year-old woman with a combined hepatitic/cholestatic syndrome. Hepatology 1995;22:1598-605.
19. Gohlke F, Lohse AW, Dienes HP, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996;24:699-705.
20. Protzer U, Dienes HP, Bianchi L, et al. Post-infantile giant cell hepatitis in patient with primary sclerosing cholangitis and autoimmune hepatitis. Liver 1996;16:274-82.
21. Luketic VA, Gomez DA, Sanyal AJ, et al. An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 1997;42:2009-16.
22. McNair AN, Moloney M, Portman BC, et al. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 1998;93:777-84.
23. Hatzis GS, Vassiliou VA, Delladetsima JK. Overlap syndrome of primary sclerosing cholangitis and autoimmune hepatitis. Eur J Gastroenterol Hepatol 2000;13:203-6.
24. Abdo AA, Bain VG, Kichian K, et al. Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome. Hepatology 2002;36:1393-9.
25. Takiguchi J, Ohira H, Shishido S, et al. Autoimmune hepatitis overlapping with primary sclerosing cholangitis. Int Med 2002;41:696-700.
26. Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
27. Boberg KM. Primary sclerosing cholangitis and cholangiocarcinoma. In: Bacon BR, Goodman ZD, Brunt EM, eds. Liver disease in the 21st century: Clinico-pathologic correlates. American Association for the study of Liver Diseases postgraduate course. 2003;172-7.